These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8245664)

  • 21. Association and management of Crohn's disease plus hidradenitis suppurativa.
    dos Santos CH; Netto PO; Kawaguchi KY; Parreira Alves JA; de Alencar Souza VP; Reverdito S
    Inflamm Bowel Dis; 2012 Apr; 18(4):E801-2. PubMed ID: 21993924
    [No Abstract]   [Full Text] [Related]  

  • 22. QUIZ HQ 40. Perineal abscesses and fistulas--always a mark of Crohn's disease?
    Gheorghe C; Cotruta B; Trifu V; Grasu M; Gheorghe L
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):307-8, 342. PubMed ID: 17944061
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease.
    Lukach AJ; Saul MI; Ferris LK; Swoger JM
    Dig Dis Sci; 2018 Mar; 63(3):755-760. PubMed ID: 29357084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study.
    Deckers IE; Benhadou F; Koldijk MJ; Del Marmol V; Horváth B; Boer J; van der Zee HH; Prens EP
    J Am Acad Dermatol; 2017 Jan; 76(1):49-53. PubMed ID: 27793450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa.
    Delobeau M; Abdou A; Puzenat E; Deveza E; Biver-Dalle C; van de Laak A; Roche-Kubler B; Vuitton L; Koch S; Wendling D; Aubin F
    J Dermatolog Treat; 2016; 27(3):251-3. PubMed ID: 26368546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
    Faivre C; Villani AP; Aubin F; Lipsker D; Bottaro M; Cohen JD; Durupt F; Jeudy G; Sbidian E; Toussirot E; Badot V; Barbarot S; Debarbieux S; Delaporte E; Goegebeur G; Morel J; Nassif A; Duru G; Jullien D;
    J Am Acad Dermatol; 2016 Jun; 74(6):1153-9. PubMed ID: 26965410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adalimumab treatment for hidradenitis suppurativa associated with Crohn's disease.
    Diamantova D; Lomickova I; Cetkovska P
    Acta Dermatovenerol Croat; 2014; 22(4):291-3. PubMed ID: 25580790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Association between Hidradenitis Suppurativa and Crohn's Disease: in Search of the Missing Pathogenic Link.
    van der Zee HH; Horvath B; Jemec GBE; Prens EP
    J Invest Dermatol; 2016 Sep; 136(9):1747-1748. PubMed ID: 27542293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and Risk of Inflammatory Bowel Disease in Patients with Hidradenitis Suppurativa.
    Egeberg A; Jemec GBE; Kimball AB; Bachelez H; Gislason GH; Thyssen JP; Mallbris L
    J Invest Dermatol; 2017 May; 137(5):1060-1064. PubMed ID: 28089682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: a case report and review of literature.
    Salvatori S; Marafini I; Monteleone G
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e1046-e1050. PubMed ID: 33905217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Characteristics of Hidradenitis Suppurativa Patients from a Reference Centre in Kaunas, Lithuania.
    Kucinskiene V; Jariene V; Valiukeviciene S
    Dermatology; 2020; 236(1):66-70. PubMed ID: 31940646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of inflammatory bowel disease (IBD) in hidradenitis suppurativa (HS): systematic review and adjusted meta-analysis.
    Phan K; Tatian A; Woods J; Cains G; Frew JW
    Int J Dermatol; 2020 Feb; 59(2):221-228. PubMed ID: 31631340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term Outcomes of Sphincter-Saving Procedures for Diffuse Crohn's Disease of the Large Bowel.
    Li Y; Stocchi L; Mu X; Cherla D; Remzi FH
    Dis Colon Rectum; 2016 Dec; 59(12):1183-1190. PubMed ID: 27824704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hidradenitis suppurativa in Crohn's disease.
    Ostlere LS; Langtry JA; Mortimer PS; Staughton RC
    Br J Dermatol; 1991 Oct; 125(4):384-6. PubMed ID: 1954129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hidradenitis suppurativa in Crohn's disease. A further support to this association.
    Tsianos EV; Dalekos GN; Tzermias C; Merkouropoulos M; Hatzis J
    J Clin Gastroenterol; 1995 Mar; 20(2):151-3. PubMed ID: 7769199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demographic and clinical features of hidradenitis suppurativa in Korea.
    Yang JH; Moon J; Kye YC; Kim KJ; Kim MN; Ro YS; Park MY; Ahn HH; Lee MW; Lee WJ; Lee JH; Lee JB; Jang MS; Choi YS; Choi YW; Suh DH;
    J Dermatol; 2018 Dec; 45(12):1389-1395. PubMed ID: 30294846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of hidradenitis suppurativa: Surgery and yeast (Saccharomyces cerevisiae)-exclusion diet. Results after 6 years.
    Aboud C; Zamaria N; Cannistrà C
    Surgery; 2020 Jun; 167(6):1012-1015. PubMed ID: 32098690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Crohn's disease and hidradenitis suppurativa: An announced crisis?].
    Cohen L; Fathallah N; Pommaret E; de Parades V; Cosnes J
    Presse Med; 2017; 46(7-8 Pt 1):777-778. PubMed ID: 28751066
    [No Abstract]   [Full Text] [Related]  

  • 40. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.
    Martínez F; Nos P; Benlloch S; Ponce J
    Inflamm Bowel Dis; 2001 Nov; 7(4):323-6. PubMed ID: 11720323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.